Professional Documents
Culture Documents
L. Vanitha
PG Scholar
Loyola Institute of Technology
Palanchur, Chennai
Assistant Professor,
Loyola Institute of Technology,
Palanchur, Chennai
The organization of this paper is as follows:
Literature survey is discussed in Section II, Section
III describes the methodology for the proposed
cardiac arrest prediction system. The different
modules of the work are executed in Matlab and the
results are summarized and discussed in Section IV.
Section V gives the conclusion and future work.
II
INTRODUCTION
LITERATURE SURVEY
III
METHODOLOGY
377
Data Acquisition
HRV Determination
Feature vector extraction
Classification
B. Feature Extraction
The time intervals between consecutive
heart beats are customarily measured in the
electrocardiogram from the beginning of a QRS
complex to the beginning of the next QRS complex,
so these intervals might be called QQ intervals, but
they are conventionally named RR intervals. The
intervals between normal (sinus) beats are usually
called NN intervals.
Heart rate variability (HRV) measures are
usually divided into two broad categories: time
domain measure and frequency domain measures. In
time domain, SDNN (Standard deviation of all NN
intervals) and RMSSD (Square root of the mean of
the squares of differences between adjacent NN
intervals) and in frequency domain of HRV
parameters consists of LF (Low frequency), HF
(High frequency) and LF/HF (Ratio of LF power to
HF power).HRV (R-R interval) is determined from
ECG signal for 0-10min, 10m 20 min, 20 30 min,
5 15 min, 15 25 min. Time domain parameters,
SDNN, RMSDD and frequency domain parameters,
LF, HF, LF/HF is determined.
HRV DETERMINATION
SVM CLASSIFIER
Normal
C. Classification
Variable definition:
1. Let x denote a vector drawn from the input
space, assumed to be of dimension mo.
2. Let {j(x)} for j=1 to m1, denote a set of
nonlinear transformations from the input space
to the feature space.
3. m1 is the dimension of the feature space.
378
D. Performance Evaluation
To evaluate the performance of the
classifier, the following statistical measures are used.
True Positive (TP): The subject is having cardiac
arrest and the classifier correctly identifies the
cardiac arrest signal.
False Positive (FP): The subject is normal but the
classifier misinterprets the subject had cardiac arrest.
(1)
Where
K(x,xi) = T(x)(xi) represents the inner product
of two vectors induced in the feature space by
the input vector x and input pattern xi pertaining
to the ith example. This term is referred to as
inner-product kernel.
where
x , x ,,
0 (x) = 1 for all x
wo denotes the bias b
(2)
(3)
(10)
K x ,x
(4)
0
C
for i 1,2, , N
0
(9)
1
2
(8)
(5)
(6)
(11)
(12)
(7)
,
(xi) is the image induced in the feature space
due to xi.
w0 represents the optimum bias b0.
IV
379
Patient 5:
TIME
SDNN
RMSSD
LF
HF
1.2628
0.1026
0.0421
0.5133
0.5084
10-20
1.3635
0.0874
0.4134
0.6860
0.7987
20-30
1.1758
0.7998
0.6376
0.6308
0.9251
05-15
1.1024
0.5606
0.2534
0.3354
0.3851
1525
1.0061
0.1525
0.0813
0.0720
0.0872
LF/HF
SDNN
RMSSD
LF
HF
LF/HF
0.3085
0.6915
HF
LF/HF
0.4462
10-20
0.0228
0.0274
0.3085
0.6915
0.4462
20-30
0.0228
0.0274
0.3085
0.6915
0.4462
05-15
0.0228
0.0274
0.3085
0.6915
0.4462
1525
0.0228
0.0274
0.3085
0.6915
0.4462
TIME
0- 10
SDNN
1.2628
RMSSD
0.1026
LF
0.0421
HF
0.5133
LF/HF
0.5084
10-20
1.3635
0.0874
0.4134
0.6860
0.7987
20-30
1.1758
0.7998
0.6376
0.6308
0.9251
05-15
1.1024
0.5606
0.2534
0.3354
0.3851
1525
1.0061
0.1525
0.0813
0.0720
0.0872
SDNN
0.2687
0.4293
0.1032
RMSSD
0.3269
0.3494
0.1867
Patient 2:
TIME
0- 10
10-20
20-30
Patient 2:
TIME
LF
0.0274
Patient 1:
Patient 1:
0- 10
RMSSD
0.0228
TIME
SDNN
0- 10
LF
0.2432
0.2401
0.2448
HF
0.7568
0.7599
0.7552
LF/HF
0.3214
0.3159
0.3242
05-15
0.0449
0.1006
0.2572
0.7428
0.3462
1525
0.0921
0.1774
0.2485
0.7515
0.3307
Patient 3:
0- 10
0.017
0.0129
0.2148
0.7852
0.2736
10-20
0.0111
0.0193
0.2151
0.7849
0.2741
20-30
0.0129
0.0142
0.2536
0.7464
0.3397
TIME
0- 10
SDNN
0.0166
RMSSD
0.0306
LF
0.2481
HF
0.7521
LF/HF
0.3298
05-15
0.0282
0.0423
0.2066
0.7934
0.2604
10-20
0.0095
0.0101
0.2522
0.7478
0.3372
0.4681
20-30
0.0066
0.0092
0.2501
0.7499
0.3335
05-15
0.0129
0.0261
0.2521
0.7479
0.3371
1525
0.0111
0.0175
0.2499
0.7501
0.3331
1525
0.0159
0.016
0.3189
0.6811
Patient 3:
TIME
SDNN
RMSSD
LF
HF
LF/HF
0- 10
0.0231
0.0183
0.29
0.71
0.4084
10-20
0.0109
0.0163
0.2524
0.7476
0.3375
20-30
0.0087
0.0155
0.2738
0.7262
05-15
0.0071
0.0142
0.2495
0.7505
1525
0.0199
0.0203
0.2857
0.7143
Patient 4:
RMSSD
LF
HF
LF/HF
0- 10
0.1918
0.1541
0.2454
0.7546
0.3252
0.3771
10-20
0.1471
0.1239
0.2321
0.7679
0.3022
0.3324
20-30
0.1909
0.1108
0.2709
0.7291
0.3716
0.4001
05-15
0.1724
0.3354
0.2232
0.7768
0.2874
1525
0.1577
0.1437
0.2484
0.7516
0.3304
TIME
Patient 4:
TIME
SDNN
Patient 5:
SDNN
RMSSD
LF
HF
LF/HF
0- 10
0.0273
0.0227
0.2145
0.7855
0.2731
10-20
0.0238
0.0245
0.2979
0.7021
0.4244
20-30
0.0473
0.0235
0.209
0.791
0.2642
05-15
0.0394
0.04
0.2017
0.7983
0.2526
1525
0.0226
0.0233
0.3177
0.6823
0.4656
TIME
380
SDNN
RMSSD
LF
HF
LF/HF
0- 10
0.0815
0.0362
0.2371
0.7631
0.3107
10-20
0.0781
0.0325
0.2532
0.7468
0.3391
20-30
0.0812
0.0903
0.2392
0.7608
0.3143
05-15
0.0661
0.0594
0.2508
0.7492
0.3348
1525
0.0789
0.0322
0.2503
0.7497
0.3339
[6]
Training
Phase
Testing
Phase
150
50
True Positive
73
23
False Positive
70
21
True Negative
False Negative
Sensitivity
2
97
2
92
Specificity
93
84
94
85
97
91
Accuracy
95
88
[7]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
REFERENCES
[1]
381